Showing results (11-20 of 1,698) with videos related to
Sort By:
Pageof 170
Cancer Research|November 14, 1997
Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigenS R Denmeade, W Lou, J Lövgren, et al.The Prostate|June 8, 2001
Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft modelsS R Denmeade, L J Sokoll, D W Chan, et al.Cancer Research|July 4, 1998
Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigenS R Denmeade, A Nagy, J Gao, et al.The Prostate|February 11, 1999
Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2A C Gao, W Lou, T Ichikawa, et al.Journal of Medicinal Chemistry|December 14, 2001
Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cellsC M Jakobsen, S R Denmeade, J T Isaacs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cellsA T Weeraratna, S L Dalrymple, J C Lamb, et al.The Prostate|August 29, 2000
In vivo activity of a PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenograftsS R Khan, S R DenmeadeCancer Research|October 1, 1985
Determination of the number of events required for mammary carcinogenesis in the Sprague-Dawley female ratJ T IsaacsThe Urologic Clinics of North America|June 11, 1999
The biology of hormone refractory prostate cancer. Why does it develop?J T IsaacsPageof 170